(Q53301316)

13 May 2018

title

Nanaomycin A Selectively Inhibits DNMT3B and Reactivates Silenced Tumor Suppressor Genes in Human Cancer Cells (English)

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

11 July 2024

2

Thomas Caulfield

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20833755

11 July 2024

José L. Medina-Franco

4

object named as

Jose L. Medina-Franco

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20833755

11 July 2024

author name string

Dirk Kuck

1

1 reference

13 May 2018

Frank Lyko

3

1 reference

13 May 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20833755

11 July 2024

publication date

10 September 2010

1 reference

13 May 2018

full work available at URL

https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Nanaomycin_A_Selectively_Inhibits_DNMT3B_and_Reactivates_Silenced_Tumor_Suppressor_Genes_in_Human_Cancer_Cells/22485183/1/files/39936732.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20833755

http://intl-mct.aacrjournals.org/cgi/content/abstract/9/11/3015

11 July 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20833755

https://aacrjournals.org/mct/article-pdf/9/11/3015/1886645/3015.pdf

11 July 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Molecular Cancer Therapeutics

11 July 2024

published in

1 reference

13 May 2018

volume

9

1 reference

13 May 2018

issue

11

1 reference

13 May 2018

page(s)

3015-3023

1 reference

13 May 2018

DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S0092-8674(00)81656-6

Nanomycins, new antibiotics produced by a strain of Streptomyces. III. A new component, nanomycin C, and biological activities of nanaomycin derivatives

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.28.925

Histones: annotating chromatin

1

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Coordinated chromatin control: structural and functional linkage of DNA and histone methylation

11 July 2024

2

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

The DNA methyltransferases of mammals

11 July 2024

3

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells

11 July 2024

4

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

EUKARYOTIC CYTOSINE METHYLTRANSFERASES

11 July 2024

5

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Cancer epigenomics: DNA methylomes and histone-modification maps

11 July 2024

7

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

DNA methyltransferase inhibitors and the development of epigenetic cancer therapies

11 July 2024

8

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells

11 July 2024

9

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

DNA methyltransferase inhibitors for cancer therapy

11 July 2024

10

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases.

11 July 2024

11

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Synthesis and in vitro evaluation of biotinylated RG108: a high affinity compound for studying binding interactions with human DNA methyltransferases

11 July 2024

12

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines.

11 July 2024

13

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols

11 July 2024

16

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation

11 July 2024

17

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Global DNA hypermethylation-associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine

11 July 2024

18

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Hydralazine target: from blood vessels to the epigenome

11 July 2024

19

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Constrained analogues of procaine as novel small molecule inhibitors of DNA methyltransferase-1.

11 July 2024

21

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Procainamide is a specific inhibitor of DNA methyltransferase 1.

11 July 2024

22

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Mithramycin A inhibits DNA methyltransferase and metastasis potential of lung cancer cells

11 July 2024

23

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Epigenetic control using natural products and synthetic molecules

11 July 2024

24

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Anticancer drug discovery targeting DNA hypermethylation

11 July 2024

25

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties

11 July 2024

26

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Antitumor antibiotics: bleomycin, enediynes, and mitomycin

11 July 2024

27

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

The mode of action of nanaomycin A in gram-positive bacteria

11 July 2024

29

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

The mode of action of nanaomycins D and A on a gram-negative marine bacterium Vibrio alginolyticus

11 July 2024

30

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Capillary electrophoretic analysis of genomic DNA methylation levels

11 July 2024

31

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Establishment and functional validation of a structural homology model for human DNA methyltransferase 1.

11 July 2024

32

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

An essential role for DNA methyltransferase DNMT3B in cancer cell survival

11 July 2024

33

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Constrained (l-)-S-adenosyl-l-homocysteine (SAH) analogues as DNA methyltransferase inhibitors

11 July 2024

34

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymes

11 July 2024

35

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation

11 July 2024

36

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.

11 July 2024

37

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

The G-C specific DNA binding drug, mithramycin, selectively inhibits transcription of the C-MYC and C-HA-RAS genes in regenerating liver

11 July 2024

38

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Mithramycin selectively inhibits transcription of G-C containing DNA.

11 July 2024

39

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Doxorubicin inhibits DNMT1, resulting in conditional apoptosis.

11 July 2024

40

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins

11 July 2024

41

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Inactivation of Dnmt3b in mouse embryonic fibroblasts results in DNA hypomethylation, chromosomal instability, and spontaneous immortalization.

11 July 2024

42

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

Molecular basis of anthracycline-induced cardiotoxicity and its prevention

11 July 2024

43

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0609

11 July 2024

Identifiers

1 reference

13 May 2018

1 reference

13 May 2018